ILD Highlights From ATS 2022 ILD Highlights From ATS 2022

Key abstracts on interstitial lung disease from ATS 2022 include results on a phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis and data showing the effect of antifibrotic drugs on mortality.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pulmonary Medicine ReCAP Source Type: news